Understanding the genetic diversity of HIV-1

AIDS

Volumn 14, Issue SUPPL. 3, 2000, Pages

  McCutchan, F E ^a  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

Author keywords

HIV 1; Recombinant; Regulatory functions; Subtype; Transmission; Viral load testing

Indexed keywords

VIRUS DNA;

BIODIVERSITY; GENE SEQUENCE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHYLOGENY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; VIRUS GENOME; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS RECOMBINANT; VIRUS TRANSMISSION;

HIV INFECTIONS; HIV-1; HUMANS; RECOMBINATION, GENETIC; VARIATION (GENETICS);

EID: 0033773876     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (204)

1. Molecular cloning of lymphadenopathy-associated virus
2. Lymphadenopathy/AIDS virus: Genetic organization and relationship to animal lentiviruses
3. Genetic variability of the AIDS virus: Nucleotide sequence analysis of two isolates from African patients
4. Complete nucleotide sequence of the AIDS virus, HTLV-III
5. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes
6. Genetic subtypes of HIV-1
7. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin
8. Genetic comparison of HIV-1 isolates from Africa, Europe, and North America
9. The emerging genetic diversity of HIV - The importance of global surveillance for diagnostics, research, and prevention
10. Global distribution of human immunodeficiency virus-1 clades
11. Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase
12. Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates
13. Recombination in HIV-1
14. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil
15. Biological and molecular characterization of subtype D, G, and A/D recombinant HIV-1 transmissions in Sweden
16. Coexistence of subtypes B, F, and a B/F env recombinant of HIV type 1 in Buenos Aires, Argentina
17. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand
18. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin
19. Primary infections with HIV-1 of women and their offspring in Rwanda: Findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C
20. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants
21. Retroviral recombination and reverse transcription
22. Retroviral recombination during reverse transcription
23. Homologous recombination of copackaged retrovirus RNAs during reverse transcription
24. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans
25. Dual infection with HIV-1 Thai subtype B and E
26. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient
27. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor
28. Identification of single and dual infections with distinct subtypes of human immunodeficiency virus type 1 by using restriction fragment length polymorphism analysis
29. HIV-1 group O and group M dual infection in Benin
30. Dual infection with different strains of the same HIV-1 subtype
31. Horizontal and vertical transmission of human immunodeficiency virus type 1 dual infections caused by viruses of subtypes B and C
32. HIV-1 genetic diversity
33. Global diversity in human immunodeficiency viruses
34. HIV-1 subtypes: Implications for epidemiology, pathogenicity, vaccines, and diagnostics
35. HIV-1 nomenclature proposal
36. HIV-1 nomenclature proposal
37. Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic
38. Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction
39. Full-length sequence of an Ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C
40. Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple
41. Characterization of subtype A HIV-1 from Africa by full genome sequencing
42. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad
43. An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)
44. A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1
45. Virtually full-length sequences of HIV type 1 subtype J reference strains
46. Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America
47. Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: A survey of over 6000 samples
48. Full genome sequencing of HIV-1 reveals new complexity in the pandemic
49. Near-full-length genome sequencing of divergent African HIV type 1 subtype F viruses leads to the identification of a new HIV type 1 subtype designated K
50. Injecting drug users in Guangxi Province, China harbor two highly homogenous, geographically separated HIV-1 strains: CRF AE and a novel BC recombinant
51. Full-length genomic sequence of an HIV type 1 subtype G from Kinshasa
52. HIV-1 subtype H near-full genome reference strains and analysis of subtype-H-containing inter-subtype recombinants
53. High diversity of HIV-1 subtype F strains in Central Africa
54. Recombinants and novel genetic forms of HIV-1 predominate in Cameroon
55. Independent introduction of transmissible F/D recombinant HIV-1 from Africa into Belgium and The Netherlands
56. Report on the global HIV/AIDS epidemic
57. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: A set of 23 full-length clones from Botswana
58. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination
59. Analysis of the first full-length genome sequences of South African HIV-1 subtype C isolates
60. HIV-1 subtype C in commerical sex workers in Addis Ababa, Ethiopia
61. Restriction fragment length polymorphism analysis for rapid gag subtype determination of human immunodeficiency virus type 1 in South Africa
62. A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations
63. Primary subtype C HIV-1 infection in Harare, Zimbabwe
64. Genetic variants of HIV-1 in Thailand
65. The molecular epidemiology of HIV in Asia
66. The march of AIDS through Asia
67. Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa
68. Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China
69. Genetic similarity of HIV type 1 subtype E in a recent outbreak among injecting drug users in northern Vietnam to strains in Guangxi Province of southern China
70. Sequence and phylogenetic analyses of HIV-1 infection in Vietnam: Subtype E in commercial sex workers (CSW) and injection drug users (IDU)
71. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia
72. Diversity of envelope glycoprotein from human immunodeficiency virus type 1 of recent seroconverters in Thailand
73. Genetic characterization of incident HIV type 1 subtype E and B strains from a prospective cohort of injecting drug users in Bangkok, Thailand
74. HIV-1 subtype E is predominant among drug users in northern Thailand
75. First Identified AE/B inter-subtype recombinant of HIV-1 is found in Thailand
76. The first HIV-1 inter-subtype recombinant between subtype C and AE is discovered in Thailand
77. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion
78. Identification of all HIV type 1 group M subtypes in Senegal, a country with low and stable seroprevalence
79. Molecular evolution of human immunodeficiency virus type 1 subtype A in Senegal: 1988-1997
80. Genetic analysis of human immunodeficiency virus in Abidjan, Ivory Coast reveals predominance of HIV type 1 subtype A and introduction of subtype G
81. Distribution of HIV-1 subtypes among HIV-seropositive patients in the interior of Cote d'Ivoire
82. Genetic diversity of HIV-1 group M from Cameroon and Republic of Congo
83. HIV type 1 genetic variability in the northern part of Cameroon
84. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa
85. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria
86. Predominance of subtype A and G HIV type 1 in Nigeria, with geographical differences in their distribution
87. Genetic subtypes of HIV type 1 in Republic of Congo
88. Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa
89. Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG
90. Genetic diversity of HIV infection worldwide and its consequences
91. Near full-length genome analysis of HIV-1 CRF02.AGIbNG-subtype C and CRF02.AGIbNG-subtype G recombinants
92. Genetic analysis of human immunodeficiency virus type 1 strains from patients in cyprus: Identification of a new subtype designated subtype I
93. An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I)
94. Molecular analysis of the full-length genome of HIV type 1 subtype I: Evidence of A/G/I recombination
95. The loss of HIV-1 subtype I
96. A novel subtype A/G/J recombinant full-length HIV type 1 genome from Burkina Faso
97. The identification of a complex A/G/I/J recombinant HIV type 1 virus in various West African countries
98. Molecular epidemiology of HIV infections in China
99. Two subtypes of HIV-1 among injection-drug users in southern China
100. Intersubtype recombinant HIV type 1 involving HIV-MAL-like and subtype H-like sequence in four Norwegian cases
101. Molecular characterization of a recombinant HIV type 1 isolate (A/G/E/?): Unidentified regions may be derived from parental subtype E sequences
102. HIV type 1 A/J recombinant with a pronounced pol gene mosaicism
103. A highly-conserved clade B human immunodeficiency virus type 1 (HIV-1) is heterosexualy transmitted in Trinidad and Tobago
104. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities
105. Emerging recombinant human immunodeficiency viruses: Uneven representation of the envelope V3 region
106. Genetic heterogeneity of HIV type 1 subtypes in Kimpese, rural Democratic Republic of Congo
107. Geographical distribution of HIV-1 group O viruses in Africa
108. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from Equitorial Guinea
109. Presence of HIV-1 group O infection in West Africa
110. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon
111. Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate
112. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from Equatorial Guinea
113. Interpatient genetic variability of HIV-1 group O
114. Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient
115. Human immunodeficiency virus type 1 intergroup (M/O) recombination in cameroon
116. Molecular epidemiology of HIV-1 in South America
117. Dual and recombinant infections: An integral part of the HIV-1 epidemic in Brazil
118. HIV-1 diversity in Brazil: Genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization
119. HIV-1 subtyping in Salvador, Bahia, Brazil: A city with African sociodemographic characteristics
120. The HIV epidemic in the Amazon Basin is driven by prototypic and recombinant HIV-1 subtypes B and F
121. Evidence of a high frequency of HIV-1 subtype F infections in a heterosexual population in Buenos Aires, Argentina
122. Identification of human immunodeficiency virus type 1 subtypes B and F B/F recombinant and dual infection with these subtypes in Argentina
123. Widespread circulation of a B/F intersubtype recombinant form among HIV-1-infected individuals in Buenos Aires, Argentina
124. Genetic epidemiology of HIV-1 infected maternity patients and their sexual partners in Buenos Aires, Argentina
125. HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network
126. Molecular epidemiology of HIV-1 in Switzerland: Evidence for a silent mutation in the C2V3 region distinguishing intravenous drug users from homosexual men. Swiss HIV Cohort Study
127. Recombinant human immunodeficiency viruses type 1 circulating in Spain
128. Presence of multiple HIV subtypes and a high frequency of subtype chimeric viruses in heterosexually infected women
129. Molecular epidemiology of vertical human immunodeficiency virus type 1 transmission in Greece: Evidence of non-B subtypes
130. The prevalence of non-B subtype HIV-1 in a London HIV/AIDS outpatient clinic
131. Human immunodeficiency virus (HIV) subtype surveillance of African-born persons at risk for group O and group N HIV infections in the United States
132. Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States
133. HIV/AIDS
134. Rapid full-length genomic sequencing of two cytopathically heterogeneous Australian primary HIV-1 isolates
135. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G
136. DNA sequence of the long terminal repeat of human immunodeficiency virus type 1 subtype A through G
137. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes
138. Dysregulation through the NF-κB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter
139. Occurrence of additional NF-κB-binding motifs in the long terminal repeat region of South African HIV type 1 subtype C isolates
140. Increased promoter diversity reveals a complex phylogeny of human immunodeficiency virus type 1 subtype C in India
141. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities
142. Elevated tumor necrosis factor-α activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-κB enhancer gain-of-function
143. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-κB enhancer element into a GABP binding site
144. Sequence features downstream of the primer-binding site of HIV type 1 subtype E shared by subtype G and a subset of subtype A
145. Differential stability of the mRNA secondary structures in the frameshift site of various HIV type 1 viruses
146. Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium binding
147. HIV-1 tropism and co-receptor use
148. HIV entry and tropism: The chemokine receptor connection
149. Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate
150. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals
151. HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism
152. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
153. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants
154. Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients
155. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
156. Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women. European Network for In Utero Transmission of HIV-1
157. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS
158. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism
159. Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region
160. Clinical disease associated with HIV-1 subtype B' and E infection among 2104 patients in Thailand
161. Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand
162. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya
163. The role of HIV-1 envelope subtypes A and D on disease progression in a large cohort of HIV-1 positive individuals in Uganda
164. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D
165. Human immunodeficiency virus type 1 subtypes differ in disease progression
166. Interaction with human immunodeficiency virus (HIV) type 2 predicts HIV type 1 genotype
167. Epidemiological characteristics of HIV infection among IDUs in Guangxi, China 1996-1999
168. The evolution of subtype C HIV-1 and its recombinant forms among IDUs in China
169. Realtive transmissibility of E and a novel BC recombinant HIV-1 in a cohort of IDUs
170. The explosive human immunodeficiency virus type 1 epidemic among injecting drug users of Kathmandu, Nepal, is caused by a subtype C virus of restricted genetic diversity
171. An HIV type 1 epidemic among injecting drug users in the former Soviet Union caused by a homogeneous subtype A strain
172. Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine
173. Sequence note - Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus
174. An HIV type 1 subtype A outbreak among injecting drug users in Latvia
175. A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union: Identification of subtype A, subtype B, and novel gagA/envB recombinants
176. The molecular epidemiology of human immunodeficiency virus type 1 in six cities in Britain and Ireland
177. An HIV-1 outbreak among Finnish IDUs caused by the circulating recombinant form AE
178. Genetic structure of subtype A, D, and inter-subtype D/A recomblnants in Rakai District, Uganda
179. Viral load and combination therapy for human immunodeficiency virus
180. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
181. Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure
182. Subtype-specific problems with quantification of plasma HIV-1 RNA
183. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain
184. Assay of plasma samples representing different HIV-1 genetic subtypes: An evaluation of new versions of the amplicor HIV-1 monitor assay
185. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes
186. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
187. Impad of HIV type 1 subtype variation on viral RNA quantitation
188. Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA
189. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1
190. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study
191. Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya
192. Evaluation of a prototype amplicor PCR assay for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults infected with HIV-1 subtypes A, C and D
193. Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor
194. Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil
195. Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults
196. Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests
197. HIV: The deadly passenger in dendritic cells
198. The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells
199. Developing standards of care for patients with HIV-1 non-B subtypes and HIV-2